Richards Ayanthi A, Colgrave Michelle L, Zhang Jialiang, Webster Julie, Simpson Fiona, Preston Elaine, Wilks Donna, Hoehn Kyle L, Stephenson Matthew, Macdonald Graeme A, Prins John B, Cooney Gregory J, Xu Aimin, Whitehead Jonathan P
Diamantina Institute for Cancer, Immunology and Metabolic Medicine, University of Queensland, Brisbane, Queensland, Australia.
Mol Endocrinol. 2010 Jan;24(1):229-39. doi: 10.1210/me.2009-0133. Epub 2009 Oct 23.
Adiponectin is an adipocyte-secreted, insulin-sensitizing hormone the circulating levels of which are reduced in conditions of insulin resistance and diabetes. Previous work has demonstrated the importance of posttranslational modifications, such as proline hydroxylation and lysine hydroxylation/glycosylation, in adiponectin oligomerization, secretion, and function. Here we describe the first functional characterization of adiponectin sialylation. Using a variety of biochemical approaches we demonstrated that sialylation occurs on previously unidentified O-linked glycans on Thr residues of the variable domain in human adiponectin. Enzymatic removal of sialic acid or its underlying O-linked sugars did not affect adiponectin multimer composition. Expression of mutant forms of adiponectin (lacking the modified Thr residues) or of wild-type adiponectin in cells defective in sialylation did not compromise multimer formation or secretion, arguing against a structural role for this modification. Activity of desialylated adiponectin was comparable to control adiponectin in L6 myotubes and acute assays in adiponectin(-/-) mice. In contrast, plasma clearance of desialylated adiponectin was accelerated compared with that of control adiponectin, implicating a role for this modification in determining the half-life of circulating adiponectin. Uptake of desialylated adiponectin by isolated primary rat hepatocytes was also accelerated, suggesting a role for the hepatic asialoglycoprotein receptor. Finally, after chronic administration in adiponectin(-/-) mice steady-state levels of desialylated adiponectin were lower than control adiponectin and failed to recapitulate the improvements in glucose and insulin tolerance tests observed with control adiponectin. These data suggest an important role for sialic acid content in the regulation of circulating adiponectin levels and highlight the importance of understanding mechanisms regulating adiponectin sialylation/desialylation.
脂联素是一种由脂肪细胞分泌的、具有胰岛素增敏作用的激素,在胰岛素抵抗和糖尿病状态下其循环水平会降低。先前的研究表明,翻译后修饰,如脯氨酸羟基化和赖氨酸羟基化/糖基化,在脂联素寡聚化、分泌和功能中具有重要作用。在此,我们描述了脂联素唾液酸化的首次功能特性。通过多种生化方法,我们证明唾液酸化发生在人脂联素可变结构域苏氨酸残基上先前未鉴定的O-连接聚糖上。酶促去除唾液酸或其 underlying O-连接糖并不影响脂联素多聚体组成。在唾液酸化缺陷的细胞中表达脂联素突变体形式(缺乏修饰的苏氨酸残基)或野生型脂联素,并不损害多聚体形成或分泌,这表明这种修饰不具有结构作用。去唾液酸化脂联素在L6肌管中的活性与对照脂联素相当,并且在脂联素基因敲除小鼠的急性实验中也是如此。相比之下,去唾液酸化脂联素的血浆清除率比对照脂联素加快,这表明这种修饰在决定循环脂联素半衰期方面具有作用。原代大鼠肝细胞对去唾液酸化脂联素的摄取也加快,提示肝脏去唾液酸糖蛋白受体发挥了作用。最后,在脂联素基因敲除小鼠中进行慢性给药后,去唾液酸化脂联素的稳态水平低于对照脂联素,并且未能重现对照脂联素在葡萄糖和胰岛素耐量试验中观察到的改善情况。这些数据表明唾液酸含量在调节循环脂联素水平中具有重要作用,并突出了理解调节脂联素唾液酸化/去唾液酸化机制的重要性。